Triasima Portfolio Management’s Boston Scientific BSX Stock Holding History

Triasima Portfolio Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,410	Closed	-$214K	–	130
2026 Q1	$214K	Sell	3,410 -85	-2%	-$6.8K	0.03%	135
2025 Q4	$333K	Sell	3,495 -45,169	-93%	-$4.43M	0.05%	128
2025 Q3	$4.75M	Buy	48,664 +2,180	+5%	+$226K	0.72%	43
2025 Q2	$4.99M	Buy	46,484 +1,915	+4%	+$194K	0.91%	37
2025 Q1	$4.5M	Buy	44,569 +3,559	+9%	+$358K	0.88%	35
2024 Q4	$3.66M	Buy	41,010 +10,800	+36%	+$951K	0.71%	45
2024 Q3	$2.53M	Buy	+30,210	New	+$2.38M	0.57%	57

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Triasima Portfolio Management's BSX Position: Q2 2026 in Review

Triasima Portfolio Management sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 3,410 shares — an estimated $214K sold.

Triasima Portfolio Management first reported a position in BSX in Q3 2024 and held it in 7 quarters. The position peaked at $4.99M in Q2 2025. 1,474 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Triasima Portfolio Management reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
Triasima Portfolio Management sold 3,410 Boston Scientific shares in Q2 2026, an estimated $214K.
Triasima Portfolio Management first reported a position in Boston Scientific in Q3 2024 and held it in 7 quarters.
Triasima Portfolio Management's Boston Scientific position peaked at $4.99M in Q2 2025.
1,474 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Triasima Portfolio Management's 13F filing for Q2 2026, filed 21 Jul 2026.